Scientists are hopeful that a well-known diabetes drug, Metformin, could be the key to living a longer and healthier life. The drug, known for its anti-inflammatory effects, is believed to protect against cancer, cognitive decline, and heart disease.
The TAME Trial, a six-year study involving 3,000 healthy adults aged 65 to 79, is currently underway to test whether Metformin can slow down the aging process and prevent disease. Researchers are optimistic that Metformin could be a groundbreaking treatment in the fight against aging-related health issues.
Connecticut’s West Hartford Mayor, Shari Cantor, and her attorney husband, Michael Cantor, are among the believers in Metformin’s potential benefits. Both in their mid-60s, the Cantors credit the drug with improving their lifestyle and overall health.
Researcher Steven Austad has suggested that Metformin could not only increase lifespan but also lower the risk of various diseases such as cancer, dementia, and cardiovascular issues. A clinical trial was strongly recommended by researchers to further investigate the observational benefits of Metformin for aging and overall health.
While some Metformin users have reported side effects like trouble building new muscle and vitamin B deficiency, the Cantors have not experienced any negative effects from taking the drug. With promising research and personal testimonies like the Cantors’, Metformin may soon become a widely used drug for not only managing diabetes but also promoting longevity and overall well-being.
